Our study of the underlying mechanism of cancer prognosis concerning pleckstrin expression may be aided by the finding that the patterns of PHLDA1, PHLDA2, and PHLDA3 co-expression regulated the clinical outcomes of individuals with certain types of cancer. The gene discussed is PHLDA3; the disease is cancer.